WallStreetZenWallStreetZen

NASDAQ: ALIM
Alimera Sciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ALIM past revenue growth

How has ALIM's revenue growth performed historically?
Company
-6.59%
Industry
6.47%
Market
14.1%
ALIM's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ALIM's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ALIM's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ALIM earnings and revenue history

Current Revenue
$55.8M
Current Earnings
-$17.1M
Current Profit Margin
-30.7%

ALIM Return on Equity

Insufficient data to display

Be the first to know when ALIM announces earnings.

ALIM Return on Assets

Current Company
-37.7%
Current Industry
5.6%
ALIM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ALIM Return on Capital Employed

Current Company
-32.02%
Current Industry
10.3%
ALIM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ALIM vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ALIM$55.78M-$8.21M-$17.13M+7.46%N/A
CYTH$1.33M-$17.67M-$17.69M+3.35%N/A
CPIX$40.06M$1.66M-$3.99M-0.02%N/A
MNKN/AN/AN/AN/AN/A
ZYNE$0.00-$36.45M-$36.66M-100.00%N/A
View Top Pharmaceutical Stocks

ALIM earnings dates

Next earnings date
Jul 25, 2023

Alimera Sciences Earnings & Revenue FAQ

What were ALIM's earnings last quarter?

On Invalid Date, Alimera Sciences (NASDAQ: ALIM) reported Q1 2023 earnings per share (EPS) of -$0.71, up 16.47% year over year. Total Alimera Sciences earnings for the quarter were -$4.98 million. In the same quarter last year, Alimera Sciences's earnings per share (EPS) was -$0.85.

If you're new to stock investing, here's how to buy Alimera Sciences stock.

What was ALIM's earnings growth in the past year?

As of Q2 2023, Alimera Sciences's earnings has grown year over year. Alimera Sciences's earnings in the past year totalled -$17.13 million.

What is ALIM's earnings date?

Alimera Sciences's earnings date is Invalid Date. Add ALIM to your watchlist to be reminded of ALIM's next earnings announcement.

What was ALIM's revenue last quarter?

On Invalid Date, Alimera Sciences (NASDAQ: ALIM) reported Q1 2023 revenue of $13.55 million up 13.85% year over year. In the same quarter last year, Alimera Sciences's revenue was $11.90 million.

What was ALIM's revenue growth in the past year?

As of Q2 2023, Alimera Sciences's revenue has grown -6.59% year over year. This is 13.06 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 6.47%. Alimera Sciences's revenue in the past year totalled $55.78 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.